Scpharmaceuticals Inc Cash Flow-to-Debt Ratio
Scpharmaceuticals Inc cash flow-to-debt ratio. Scpharmaceuticals Inc (SCPH) has a Cash Flow-to-Debt Ratio of -0.16x as of June 2025, meaning its operating cash flow of $-16.11 Million could theoretically repay 0% of its total liabilities ($101.57 Million) in one year. See Scpharmaceuticals Inc (SCPH) flexibility index to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Scpharmaceuticals Inc (2015–2024)
Cash flow-to-debt ratio of Scpharmaceuticals Inc from 2015 to 2024. Historical debt coverage capacity for Scpharmaceuticals Inc across 10 annual periods. Also explore net asset momentum of Scpharmaceuticals Inc to track the company's year-over-year net asset growth rate.
Scpharmaceuticals Inc Cash Flow-to-Debt Ratio by Year (2015–2024)
Scpharmaceuticals Inc cash flow-to-debt ratio by year from 2015 to 2024. Year-by-year debt coverage analysis for Scpharmaceuticals Inc. For the full cash flow conversion analysis, see Scpharmaceuticals Inc (SCPH) cash conversion ratio.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -0.75x | $-70.54 Million | $94.20 Million | ▲ +27.6% |
| 2023 | -1.03x | $-59.24 Million | $57.26 Million | ▼ -54.9% |
| 2022 | -0.67x | $-34.58 Million | $51.76 Million | ▲ +44.5% |
| 2021 | -1.20x | $-27.15 Million | $22.57 Million | ▼ -16.8% |
| 2020 | -1.03x | $-27.69 Million | $26.88 Million | ▲ +12.3% |
| 2019 | -1.17x | $-30.44 Million | $25.92 Million | ▲ +38.8% |
| 2018 | -1.92x | $-28.81 Million | $15.01 Million | ▼ -35.8% |
| 2017 | -1.41x | $-22.68 Million | $16.05 Million | ▼ -602.6% |
| 2016 | -0.20x | $-15.46 Million | $76.85 Million | ▲ +58.1% |
| 2015 | -0.48x | $-9.64 Million | $20.09 Million | — |